IL6 and neoplasm: In cancer-related immunology, immune cells exerted anti-tumor capacity through different mechanisms such as binding ligands on the surface of tumor cells through self-surface receptors; meanwhile, pro-inflammatory and immunomodulatory cytokines such as IL-12, TNF-α, IFN-γ, and IL-6 were released during the process.